Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-06 Antihistamines
Links
Administration of depot antipsychotic injections during COVID-19 in stable adult patients- MHRA: New advice for domperidone (April 2014)
- MHRA: New advice for domperidone (April 2014)
- MHRA: New advice for domperidone (April 2014)
- MHRA: Restricted dose and duration of use (August 2013)
- MHRA: Restricted dose and duration of use (August 2013)
NICE CG84: Vomiting and diarrhoea in children under 5- NICE ES20: Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy
- NICE NG59: Low back pain and sciatica in over 16s: assessment and management
- NICE: Promoting tolerance of enteral feeds in children and young people: domperidone
- NICE: Promoting tolerance of enteral feeds in children and young people: domperidone
- NICE: Promoting tolerance of enteral feeds in children and young people: domperidone
- Primary care summary - Dexamethasone in the treatment of COVID-19
UKMI Q&A: Anti-emetic treatment during pregnancy- UKMI Q&A: Hypersalivation – can hyoscine hydrobromide be used to treat it?
- UKMI Q&A: Hypersalivation treatment options
- UKMI Q&A: Hypersalivation treatment options
- UKMI Q&A: Hypersalivation-can hyoscine hydrobromide be used to treat it?
- UKMI Q&A: Lactation stimulation: Domperidone/Metoclopramide